Aristeia Capital L.L.C. Purchases New Position in Stericycle, Inc. (NASDAQ:SRCL)

Aristeia Capital L.L.C. purchased a new stake in Stericycle, Inc. (NASDAQ:SRCL) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 9,628 shares of the business services provider’s stock, valued at approximately $560,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Vanguard Personalized Indexing Management LLC increased its position in shares of Stericycle by 14.2% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 5,653 shares of the business services provider’s stock worth $280,000 after purchasing an additional 705 shares in the last quarter. Corient Private Wealth LLC increased its position in Stericycle by 52.8% during the fourth quarter. Corient Private Wealth LLC now owns 10,397 shares of the business services provider’s stock worth $515,000 after buying an additional 3,591 shares during the period. TD Asset Management Inc lifted its stake in Stericycle by 20.4% in the fourth quarter. TD Asset Management Inc now owns 44,902 shares of the business services provider’s stock valued at $2,225,000 after buying an additional 7,614 shares during the last quarter. Treasurer of the State of North Carolina boosted its holdings in shares of Stericycle by 1.0% in the fourth quarter. Treasurer of the State of North Carolina now owns 40,838 shares of the business services provider’s stock valued at $2,024,000 after acquiring an additional 400 shares during the period. Finally, TFO Wealth Partners LLC grew its position in shares of Stericycle by 22,325.0% during the fourth quarter. TFO Wealth Partners LLC now owns 897 shares of the business services provider’s stock worth $44,000 after acquiring an additional 893 shares during the last quarter. Institutional investors and hedge funds own 98.82% of the company’s stock.

Analysts Set New Price Targets

Several research firms recently commented on SRCL. Keefe, Bruyette & Woods upped their price target on shares of Stericycle from $135.00 to $142.00 and gave the company an “outperform” rating in a research report on Tuesday, June 4th. StockNews.com initiated coverage on shares of Stericycle in a research note on Tuesday, September 17th. They set a “hold” rating for the company. Royal Bank of Canada restated a “sector perform” rating and issued a $62.00 price target (down previously from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Finally, Truist Financial increased their price objective on Stericycle from $50.00 to $62.00 and gave the stock a “hold” rating in a research report on Tuesday, June 4th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $74.00.

Stericycle Stock Performance

Shares of Stericycle stock opened at $61.68 on Tuesday. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55. The firm has a market cap of $5.73 billion, a price-to-earnings ratio of -280.36, a price-to-earnings-growth ratio of 3.37 and a beta of 1.11. Stericycle, Inc. has a 52-week low of $37.78 and a 52-week high of $61.77. The company’s 50-day simple moving average is $59.40 and its 200-day simple moving average is $54.92.

Stericycle (NASDAQ:SRCL) last posted its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.61 EPS for the quarter, beating the consensus estimate of $0.57 by $0.04. Stericycle had a return on equity of 7.94% and a net margin of 1.37%. The business had revenue of $661.60 million during the quarter, compared to analysts’ expectations of $672.07 million. As a group, equities research analysts anticipate that Stericycle, Inc. will post 2.29 earnings per share for the current year.

Stericycle Company Profile

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.